百时美施贵宝

最新新闻

• A Quick Look at Today's Ratings for Bristol-Myers Squibb(BMY.US), With a Forecast Between $41 to $80
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 评级变动
  Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  UBS Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $80
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• 评级变动
  RBC Capital Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $64
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Barclays Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  Bernstein Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  J.P. Morgan Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $73
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  RBC Capital Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $64
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  HSBC Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• A Quick Look at Today's Ratings for Bristol-Myers Squibb(BMY.US), With a Forecast Between $66 to $82
  \u5e02\u573a\u8d44\u8baf · 2026/10/10
• Wells Fargo Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  BofA Securities Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $71
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  Argus Research Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Announces Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Piper Sandler Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Raises Target Price to $82
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  William Blair Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Wells Fargo Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• A Quick Look at Today's Ratings for Bristol-Myers Squibb(BMY.US), With a Forecast Between $60 to $82
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  Morgan Stanley Maintains Bristol-Myers Squibb(BMY.US) With Sell Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• Morgan Stanley Maintains Bristol-Myers Squibb(BMY.US) With Sell Rating, Raises Target Price to $41
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  BMO Capital Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $60
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  A Quick Look at Today's Ratings for Bristol-Myers Squibb(BMY.US), With a Forecast Between $65 to $80
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Piper Sandler Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $66
  \u5e02\u573a\u8d44\u8baf · 2026/7/16

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。